Actively Recruiting
Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic Lesions
Led by University Hospital, Strasbourg, France · Updated on 2025-12-24
80
Participants Needed
1
Research Sites
181 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease described in boxing, but also in contact sports such as American football. Soccer, due to repeated headers, could also be associated, albeit to a lesser degree, with the development of this type of pathology. Indeed, it has been shown that playing soccer can be accompanied by cognitive impairments, and neurodegenerative brain abnormalities have been described in neuropathology studies of former professional soccer players. Subradiological brain abnormalities have been found in multimodal MRI in various sports. Similarly, a decrease in cognitive performance has been described. The discovery of this type of anomaly in a population of professional footballers nearing the end of their careers could lead to: * The implementation of appropriate monitoring for professional footballers through early detection of lesions via MRI and cognitive disorders * The implementation of preventative measures for professional footballers, but also for amateur footballers from a very young age.
CONDITIONS
Official Title
Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male subject
- Aged 32 to 60 years inclusive
- Professional footballer nearing the end of their career or recently retired, or subject who has never regularly participated in sports that expose them to head trauma (particularly rugby, basketball, handball, American football, hockey, combat sports, etc.)
You will not qualify if you...
- Subject who expressed their opposition to participating in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service d'Imagerie 2 - Réanimation - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
S
Stéphane KREMER, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here